Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation

Major ABO mismatching is not considered a contraindication to allogeneic haematopoietic stem cell transplantation (HSCT). Modern reduced-intensity conditioning and reduced-toxicity regimens cause much less myeloablation than conventional myeloablative regimens, such as cyclophosphamide with busulfan...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Aung, Fleur M., Lichtiger, Benjamin, Bassett, Roland, Liu, Ping, Alousi, Amin, Bashier, Qaiser, Ciurea, Stefan O., de Lima, Marcos J., Hosing, Chitra, Kebriaei, Partow, Nieto, Yago, Oran, Betul, Parmar, Simrit, Qazilbash, Muzaffar, Shah, Nina, Khouri, Issa, Champlin, Richard E., Popat, Uday
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4078723/
https://ncbi.nlm.nih.gov/pubmed/23330820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12210
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi